LEXINGTON, Ky. (March 15, 2021) — Throughout the past few years, the University of Kentucky’s Department of Neurology has experienced tremendous growth. As part of this growth, the Child Neurology division outgrew its clinic space within the Kentucky Clinic.
News
LEXINGTON, Ky. (May 5, 2021) — Collaborative research between the University of Kentucky and the University of Southern California (USC) suggests that a noninvasive neuroimaging technique may index early-stage blood-brain barrier (BBB) dysfunction associated with small vessel disease (SVD). Cerebral SVD is the most common cause of vascular cognitive impairment, with a significant proportion of cases going on to develop dementia.
LEXINGTON, Ky. (April 16, 2021) — Dr. Larry Goldstein, chair of the University of Kentucky Department of Neurology, has been elected to serve on the board of directors of The American Academy of Neurology (AAN). Goldstein also is co-director of the Kentucky Neuroscience Institute, co-director of the UK Neuroscience Research Priority Area and interim director of the UK-Norton Healthcare Stroke Care Network.
LEXINGTON, Ky. (April 14, 2021) — UK HealthCare’s Multiple Sclerosis (MS) Center, a part of the Kentucky Neuroscience Institute, is celebrating one of its biggest achievements since it was created about three decades ago.
LEXINGTON, Ky. (April 12, 2021) — Four outstanding recipients who profoundly contribute to issues that affect women at the University of Kentucky and across the Commonwealth received the Sarah Bennett Holmes Award Tuesday, March 23, during a virtual awards ceremony. Christina Walker, staff winner; Hana Khamfroush, faculty winner; Mel Lesch, graduate student winner; and UK Department of Neurology's Wellness and Resiliency Committee, team winner, received the 2021 Sarah Bennett Holmes Award.
On behalf of the Office of Faculty Affairs and Development, the University of Kentucky College of Medicine is pleased to announce that Sally Mathias, MD, and Sylvia Ofei, MD, MPH, have been selected as fellows for the 2021 Bluegrass Higher Education Consortium Academic Leadership Academy (BHEC-ALA).
Dr. Mathias and Dr. Ofei will join a total of 63 faculty members at the University of Kentucky who have previously participated in this regional academic leadership program.
Ima Ebong, MD, MS, assistant professor in the University of Kentucky College of Medicine Department of Neurology, was recently named one of “1,000 Inspiring Black Scientists in America” in a list published by Cell Mentor, an online resource for researchers.
The list, compiled by The Community of Scholars, recognizes the significant contributions Black scientists have made in research.
PLAY VIDEO: Dr. Daniel O. Lee, Kentucky Neuroscience Institute Medical Director, explains how he found a solution to cure a case of encephalitis, a swelling in the brain, caused by COVID-19
Shelby Ponder thought her bout with COVID-19 was nothing to write home about: her mild, strep-like symptoms cleared up in a few days.
LEXINGTON, Ky. (Feb. 11, 2021) — At age 13, Robert Baumann began working at a children’s camp owned by his family, shaping his desire to find a career in which he could help children. “I also thought the brain and neurology were just fascinating. So, it turned out to be the only logical combination.”
LEXINGTON, Ky. (Feb. 8, 2021) — Dr. Larry Goldstein, chair of the University of Kentucky’s Department of Neurology, defends and elaborates on a recent statement by the U.S. Preventive Services Task Force (USPTF) in an editorial recently published in The Journal of the American Medical Association (JAMA). The USPTF statement reaffirmed its 2014 recommendation against screening for asymptomatic carotid artery stenosis in the general adult population.
Ima Ebong, MD, MS, assistant professor in the University of Kentucky College of Medicine Department of Neurology, was recently named one of “1,000 Inspiring Black Scientists in America” in a list published by Cell Mentor, an online resource for researchers.
The list, compiled by The Community of Scholars, recognizes the significant contributions Black scientists have made in research.
LEXINGTON, Ky. (Jan. 26, 2021) — Newly published research has found familiar music can elicit an extended emotional response in patients with Alzheimer’s-type dementia. The findings from this potential new approach were featured in issue three of volume 78 of the Journal of Alzheimer’s Disease.
LEXINGTON, Ky. (Jan. 20, 2021) — More than 5.7 million Americans live with Alzheimer’s disease and that number is projected to triple by 2050. Despite that growing number, there is not yet a cure.
The University of Kentucky Public Relations & Strategic Communications Office provides a weekly health column available for use and reprint by news media. This week's column is by Dr. Larry Goldstein, chair of the Department of Neurology, Co-director of the Kentucky Neuroscience Institute, and Interim director of the UK-Norton Stroke Care Network.
LEXINGTON, Ky. (Nov. 4, 2020) – In America, 3.5 million people have epilepsy. Approximately one in 26 people in the United States will develop epilepsy at some point in their lifetime. In Kentucky, more than 2% of the population is living with this neurologic condition characterized by unpredictable seizures.
LEXINGTON, Ky. (Aug. 10, 2020) — Most of us have heard the phrase that some stress is good. Timothy Ainger, Ph.D., assistant professor in the University of Kentucky Department of Neurology, says the word ‘some’ is key. Ainger specializes in neuropsychology which is the brain-behavior relationship. He says it is true that a small to moderate amount of stress or pressure does help a person focus and perform at their best.
LEXINGTON, Ky. (July 14, 2020) - A time for action.
LEXINGTON, Ky. (May 26, 2020) — The COVID-19 pandemic, with reported cases in more than 200 countries, is a worldwide crisis challenging all aspects of health care systems around the globe. Managing the pandemic has required some drastic changes and allocation of resources. This is affecting the delivery of care for health conditions that can be unrelated to COVID-19. Experts in various fields across health care are working to adjust to the changes to ensure they provide the best care during this time while also protecting themselves and their colleagues.
Multiple sclerosis (MS) is the most common demyelinating disorder in young adults but getting an accurate diagnosis can be tricky. The diagnosis is difficult as there is not one single test that can determine if someone has the disease.
LEXINGTON, Ky. (LEX 18) — A disturbing trend has been noticed by several doctors in a handful of hospitals in America. Otherwise healthy men in the 20-50 age range, with little to no COVID-19 symptoms, are landing in the emergency room after suffering a stroke. Some of these victims fall into a category of least-likely-to-suffer-a stroke, with most happening in those who are well below the median age for sustaining such a medical episode.
“Anybody, from babies to folks in their very elderly years,” Dr. Larry Goldstein said of the risk of suffering a stroke.